The prescribed dosage for NovoSeven RT may vary depending on a person’s individual treatment plan. Other factors, including your specific diagnosis, body weight, and medical history, may affect ...
Catalyst Biosciences is a step closer to challenging Novo Nordisk’s NovoSeven in the haemophilia A and B market after reporting positive results in a phase 2 trial. The US biotech’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback